Novo Nordisk B A/S Stock Price ($NOVO-B.CO), Quote & News

Trade

Novo Nordisk B A/S price

1.30% Past Week

Market Cap

3.99T

Day’s Range

879.17

894.25

52W Range

613.18

1031.65

Volume (3M)

2.37M

Price-Earnings Ratio

44.87

Revenue

258B

Novo Nordisk B A/S Latest News

View All

Novo Nordisk shares sink on medicare price negotiation fearsCNBCabout 14 hours ago

Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right NowThe Motley Fool6 days ago

Top Discussions

@jwesth

United Kingdom

about 3 hours ago

𝘼𝙢𝙚𝙧𝙞𝙠𝙖𝙣𝙨𝙠 𝙫𝙖𝙡𝙜 - 𝙝𝙫𝙖𝙙 𝙗𝙚𝙩𝙮𝙙𝙚𝙧 𝙙𝙚𝙩 𝙛𝙤𝙧 𝙙𝙞𝙣𝙚 𝙞𝙣𝙫𝙚𝙨𝙩𝙚𝙧𝙞𝙣𝙜𝙚𝙧? 🗳️ Vi er midt i den amerikanske valgkamp, og om mindre end to måneder skal amerikanerne til stemmeurnerne. Med USA og $SPX500 som dominerer de globale finansielle markeder og udgør ca. 60 pct.... Show More Translate

@burak0085

Denmark

8 days ago

Edited

Part 9 GFI has experienced a challenging 2024, marked by a 20% production decline due to operational setbacks and adverse weather conditions. Despite this, the company reported positive cash flow from all operations and continues to focus on strategic growth. Notably, it made progress in its decarbonization... Show More

@JordiReina

Spain

10 days ago

Investment Opportunity: The 10 trillion Market for Weight Loss Drugs As obesity rates continue to rise globally, a significant investment opportunity is emerging in the weight loss pharmaceutical sector. Two major players, $NOVO-B.CO (Novo Nordisk B A/S) $GOLD and $LLY (Eli Lilly & Co) are leading... Show More

@FabiGoesForGold

Germany

12 days ago

It has now been almost 5 years since I chose etoro as my main broker. In the meantime, individual stocks and sectors have emerged in my portfolio that are simply performing better and I'm not surprised that it's the medical and tech sectors. What surprises me is that Parker Hannifin has always... Show More

@jwesth

United Kingdom

13 days ago

𝙄𝙨 𝙂𝙪𝙗𝙧𝙖 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙬𝙚𝙞𝙜𝙝𝙩 𝙡𝙤𝙨𝙨 𝙬𝙞𝙣𝙣𝙚𝙧? 📈 Danish biotech company $GUBRA.CO (Gubra A/S) has skyrocketed in 2024 and is suddenly on the radar of many retail investors. Since its listing on Nasdaq Copenhagen at a price of DKK 110 in March 2023, the share price has risen by... Show More

@capimatt

United Kingdom

15 days ago

Performance since Portfolio start in 2018: +100% ✅ Performance this year: +28% ✅ Target ROI: +30% annually ✅ 𝑬𝒕𝒐𝒓𝒐 𝑾𝒆𝒆𝒌𝒍𝒚 𝑼𝒑𝒅𝒂𝒕𝒆 - 𝑪𝒂𝒑𝒊𝒎𝒂𝒕𝒕 Hi Everyone. There is still lots of volatility around at the moment, and today has sparked a sell off to start the trading month in US... Show More

@LucasBotteleth

Denmark

5 days ago

Novo Nordisk's new pill is safe and can lead to a 25% weight loss. By the end of the year, the company is expected to present crucial phase 3 results for Cagrisema, which is anticipated to achieve this level of weight loss. It stands out in its class. Furthermore, it is expected that Novo Nordisk... Show More

Over 1000 end year

100.00%

Under 1000 end year

100.00%

@Brandt_2022

Denmark

17 days ago

🅱🆄🅸🅻🅳 🆈🅾🆄🆁 🅾🆆🅽 🅼🅾🅽🅴🆈 🆃🆁🅴🅴 💵 Dividend payments every month The dividend received in August comes from my wealth accumulation portfolio through passive income generated by stable and reliable companies. These companies have consistently increased or maintained their dividends for... Show More

@robchamow

Spain

19 days ago

📌 The Eurozone Moves Toward Stability: Inflation Hits Its Lowest Point Since 2021 📊Annual inflation in the Eurozone rose by 2.2% in August 2024, slowing down from the 2.6% recorded in July. This outcome, which aligns with market expectations, marks the most moderate increase in consumer prices since... Show More

@DanielDanick

Spain

21 days ago

🔔🔔 $LLY (Eli Lilly & Co) launches new weight loss drug at lower price point 🔔🔔 Pharmaceutical company $LLY Lilly began offering initial doses of its low-cost weight loss drug, Zepbound, in single-dose vials, a move the company says will significantly increase the drug's availability. Its... Show More